InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by DeSutter Robert Andrew, Director. Officer active across 1 company, notably Sanara MedTech Inc.. Cumulatively, 6 reports have been logged. History available since 9 February 2022. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
5,539 shares0Common StockSEC:0001493152-26-027586:0
3,746 shares0Common StockSEC:0001641172-25-012543:0
3,932 shares0Common StockSEC:0001493152-24-023959:0
2,936 shares0Common StockSEC:0001493152-23-020182:0
5,256 shares0Common StockSEC:0001493152-22-018958:0
4,887 shares0Common StockSEC:0001493152-22-004097:0
6 of 6 declarations
About DeSutter Robert Andrew
Robert Andrew DeSutter is a Director at Sanara MedTech Inc. He contributes to the governance of the company, bringing his expertise in the medical technology sector. His experience helps guide strategic decisions.
